Aktivne farmacevtske sestavine
Progestogen in estrogen | |||
Ime izdelka | Specifikacija | Odobreno | Cas št. |
Progesteron | CP/EP/USP/JP | CEP/EU-GMP/FDA | 57-83-0 |
Menenolon | Notranja |
Košer | 145-13-1 |
Medroxyprogesteron Acetat | CP/EP/USP/JP | DMF/GMP | 71-58-9 |
Megerol acetat | CP/EP/USP | DMF v postopku | 595-33-5 |
Mifepriston | Cp/ip | DMF/GMP | 84371-65-3 |
Ciproteron acetat | CP/EP/IP/KP | CEP/TGA/EU-GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP/IP | CEP/GMP | 797-63-7 |
Norethisterone |
CP/EP/USP/JP |
DMF v postopku |
68-22-4 |
Norethisterone acetat |
EP/USP |
DMF v postopku |
51-98-9 |
Norethisterone enanthat |
Notranja |
Pod raziskavo in razvoj |
3836-23-5 |
Drospirenon | EP/USP | DMF | 67392-87-4 |
Gestoden | CP/EP | DMF/GMP | 60282-87-3 |
Estradiol | CP/EP/USP/KP | DMF/GMP/WC | 35380-71-3 |
Estriol | CP/EP/USP | Pod raziskavo in razvoj | 50-27–1 |
Etinilni estradiol | CP/EP/USP | GMP | 57-63-6 |
Estradiol valerat | CP/EP/USP/KP | DMF | 979-32-8 |
Estradiol cipionat |
USP | DMF v postopku |
313-06-4 |
Tubulon | CP/EP | DMF/GMP | 5630-53-5 |
Dienogest | Ep | CEP/GMP | 65928-58-7 |
Fulvestrant | EP/USP | Pod raziskavo in razvoj | 129453-61-8 |
Exemestane | CP/EP/USP | Pod raziskavo in razvoj | 107868-30-4 |
Androgen | |||
Ime izdelka | Specifikacija | Odobreno | Cas št. |
Finasterid | CP/EP/USP | CEP / FDA / PMDA / GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
Abirateron acetat | CP/USP | DMF/WC | 154229-18-2 |
Darolutami |
Notranja |
Pod raziskavo in razvoj |
1297538-32-9 |
Testosteron | CP/EP/USP | CEP/WC/FDA | 58-22-0 |
Testosteron undecanoat | Cp | DMF/WC | 5949-44-0 |
Testosteron cipionat | USP | Pod raziskavo in razvoj | 58-20-8 |
Testosteron enanthat |
USP/JP | Pod raziskavo in razvoj |
315-37-7 |
Testosteron propionat |
CP/EP/USP/JP |
Pod raziskavo in razvoj |
57-85-2 |
DHEA (praces) | Fp/Notranja | DMF/WC/Kosher | 53-43-0 |
Claskoteron | Notranja | DMF v postopku | 19608-29-8 |
Kortikalni hormon | |||
Ime izdelka | Specifikacija | Odobreno | Cas št. |
Budesonide | CP/EP/USP/JP | CEP/FDA/GMP | 51333-22-3 |
Deson | CP/USP | DMF/GMP | 638-94-8 |
Eplerenone | Ep | CEP v postopku | 107724-20-9 |
Metilprednizolon | CP/EP/USP/JP | DMF/GMP | 83-43-2 |
Metilprednizolon Hemisukcinat | CP/EP/USP | DMF/GMP | 2921-57-5 |
Flutikazon propionat | CP/EP/USP | DMF | 80474- 14-2 |
Fluticazon bes | CP/EP | DMF v postopku | 397864-44-7 |
Mometasone furoate |
CP/EP/USP |
DMF v postopku |
Brezvodni (83919-23-7) Monohidrat (141646-00-6) |
Deflazakort |
Notranja |
Pod raziskavo in razvoj |
14484-47-0 |
Drugi | |||
Ime izdelka | Specifikacija | Odobreno | Cas št. |
Oxcarbazepin | CP/EP/USP/IP | CEP/FDA/GMP | 28721-07-5 |
Eslicarbazepin acetat | CP/USP | DMF | 236395- 14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciclovir Hidroklorid | USP/EP | CEP v postopku | 175865-59-5 |
Osetamivir fosfat | CP/EP/USP | DMF | 204255- 11-8 |
Baloxavir Marboxil | Notranja | Pod raziskavo in razvoj | 1985606-14-1 |
Revefenacin | Notranja | DMF | 864750-70-9 |
Mirabegron | CP/EP | DMF | 223673-61-8 |
Vibegron |
Notranja |
Pod raziskavo in razvoj |
1190389-15-1 |
Escitalopram oksalat | CP/EP/USP | DMF v postopku | 219861-08-2 |
Citalopram hidrobromid |
CP/EP/USP |
DMF v postopku |
59729-32-7 |
Kariprazin hidroklorid | Notranja | DMF | 1083076-69-0 |
Lasmiditan Succinate | Notranja | DMF | 439239-92-6 |
Luliconazol | Notranja | DMF | 187164-19-8 |
Apalutami | Notranja | DMF | 956104-40-8 |
Tadalafil | CP/EP/USP | Pod raziskavo in razvoj | 171596-29-5 |
Replagolix | Notranja | DMF v postopku | 737789-87-6 |
Ruxolitinib fosfat |
Notranja |
DMF v postopku |
1092939-17-7 |
Abemaciclib |
Notranja |
Pod raziskavo in razvoj |
1231929-97-7 |
Phloroglucinol | CP/EP | DMF | 108-73-6 |
1,3,5-trimetoksibenzen |
CP/Inter |
GMP |
621-23-8 |
Ursodeoksiholična kislina | EP/USP/JP | Pod raziskavo in razvoj | 128-13-2 |
Tauroursodeoksiholična kislina |
Notranja |
Pod raziskavo in razvoj |
14605-22-2 |
Holesterol |
CP/EP/USP/JP |
Pod raziskavo in razvoj |
57-88-5 |
Omega-3-kislinski etilni etri 90 |
EP/USP |
DMF v postopku |
—— |
Trigliceridi srednje verige |
CP/USP/EP |
DMF |
—— |
Benzalkonijev klorid |
USP/EP/JP |
CEP v postopku |
8001-54-5 |
Oljčno olje (za injiciranje) |
CP/USP/EP/JP |
DMF v postopku |
8001-25-0 |
Jajčni fosfolipidi (za injiciranje) |
CP/USP/EP |
DMF |
93685-90-6 |
Prigrizek |
Notranja |
DMF v postopku |
203787-91-1 |
Za metilprednizolon hemisukcinat imamo specifikacije EP, USP in CP. DMF in WC na voljo.
Za Cyproterone Acetate (CPA) imamo na voljo specifikacije CP in EP, CEP/TGA/EU-GMP.
Levonorgestrel ima specifikacije CP/EP/USP. Na voljo so DMF, GMP in CEP.
Mifepriston ima specifikacije CP in IP. DMF in GMP sta odobrena.
Tibolon je skladen s specifikacijo EP. DMF je odobren.
Estradiol hemihidrat ima specifikacijo USP in EP. DMF na voljo.